Study Uncovers Biomarkers Linked to Chemotherapy Response in NSCLC Patients Carrying EGFR Variants
Cellworks Opens a Computational Laboratory to Advance Personalized Therapy Decision Support
Thymic tumors, while rare, are classified as orphan diseases due to their infrequency. Despite their rarity, they are the predominant tumors found in the anterior mediastinal compartment among adults.
Thymic tumors represent a wide variety of tumors and the most recent histologic classification classifies them as thymomas, thymic carcinomas (TC), and neuroendocrine thymic tumors (NETT). Although thymic tumors have traditionally been considered orphan diseases, in the last few decades there has been an increased interest in thymic malignancies in the scientific community.
Peer-Reviewed Research Indicates Whole Genome Biosimulation Holds Promise for Personalized Therapy Selection in Clinical Settings
Cancer cells are endowed with capabilities for uninhibited proliferation, invasion and metastasis. Historically, cancers have been classified based on the tissue of origin. Although this practice has been useful in terms of differentiating cancer types, we now realize the approach in the current context has limitations in terms of usage of therapeutic options available and the associated clinical response is poor.
Leader in Personalized Therapy Biosimulation Applies its Platform to Precision Drug Development
Personalized Therapy Biosimulation Uncovers a Spectrum of Genomic Aberrations that Predict Response to HMA in Myelodysplastic Syndrome Patients
Personalized Therapy Biosimulation Identifies m-MGMT GBM Patients Who Will Develop Early Progression on Temozolomide